Abstract
Cr (VI) compounds are widely used in industries and are recognized human carcinogens. The mechanism of carcinogenesis associated with these compounds is not well understood. The present study focused on Cr (VI)‐induced cell growth arrest in human lung epithelial A549 cells, using flow cytometric analysis of DNA content. Treatment of the cells with Cr (VI) at 1 μM caused a growth arrest at G2/M phase. An increase in Cr (VI) concentration enhanced the growth arrest. At a concentration of 25 μM, Cr (VI)‐induced apoptosis became apparent. Superoxide dismutase (SOD) or sodium formate did not alter the Cr (VI)‐induced cell growth arrest. While catalase inhibited growth, indicating H2O2 is an important mediator in Cr (VI)‐induced G2/M phase arrest. Electron spin resonance (ESR) spin trapping measurements showed that incubation of cells with Cr (VI) generated hydroxyl radical (•OH). Catalase inhibited the •OH radical generation, indicating that H2O2 was generated from cells stimulated by Cr (VI), and that H2O2 functioned as a precursor for •OH radical generation. The formation of H2O2 from Cr (VI)‐stimulated cells was also measured by the change in fluorescence of scopoletin in the presence of horseradish peroxidase. The mechanism of reactive oxygen species generation involved the reduction of molecular oxygen as shown by oxygen consumption assay. These results support the following conclusions: (a) Reactive oxygen species are generated in Cr (VI)‐stimulated A549 cells through reduction of molecular oxygen, (b) Among the reactive oxygen species generated, H2O2 played a major role in causing G2/M phase arrest in human lung epithelial cells.
Similar content being viewed by others
References
De Flora S, Serra D, Basso C, Zanacchi P: Mechanistic aspects of chromium carcinogenicity. Arch Toxicol 13(suppl): 28–39, 1989
Freeman N, Stern AH, Lioy PJ: Exposure to chromium dust from homes in a chromium surveillance project. Arch Environ Health 52: 213–219, 1997
World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France, 1990
Enterline PE: Respiratory cancer among chromate workers. J Occup Med 16: 523–526, 1974
Norseth T: The carcinogenicity of chromium. Environ Health Perspect 40: 121–130, 1981
De Flora S, Wetterhahn KE: Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 7: 169–244, 1989
Connett PH, Wetterhahn KE: Metabolism of the carcinogen chromate by cellular constituents. Struct Bonding 54: 93–124, 1983
Venitt S, Levy L: Mutagenicity of chromates in bacteria and its relevance to chromate carcinogenicity. Nature 250: 493–495, 1974
Shi X, Dalal NS: Role of superoxide radical in chromium (VI) generated hydroxyl radical: The Cr (VI) Haber-Weiss cycle. Arch Biochem Biophys 292: 323–327, 1992
Jennette KE: Microsomal reduction of the carcinogen chromate reduces chromium (V). J Am Chem Soc 104: 874–875, 1982
Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn KE: Reaction of chromium (VI) with hydrogen peroxide in the presence of glutathione: Reactive intermediates and resulting DNA damage. Chem Res Toxicol 3: 595–603, 1990
Sugiyama M: Effects of vitamin E and vitamin B2 on chromate-induced DNA lesions. Biol Trace Element Res 21: 399–404, 1989
Kortenkamp A, Oeken G, Beyersmann D: The DNA cleavage induced by a chromium (V) complex and by chromate and glutathione is mediated by activated oxygen species. Mutat Res 232: 155–161, 1990
Sugiyama M, Ando A, Ogura R: Effect of vitamin E on survival, glutathione reductase and formation of chromium (V) in Chinese Hamster V-79 cell treated with sodium chromate (VI). Carcinogenesis 10: 737–741, 1989
Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V: Reduction of chromium (VI) and its relationship to carcinogenesis. J Toxicol Environ Health 2: 87–104, 1999
Leonard SS, Wang S, Zang L, Castranova V, Vallyathan V, Shi X: Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr (VI) reduction and its implication to Cr (VI)-induced carcinogenesis. J Environ Pathol Toxicol Oncol 19: 49–60, 2000
Shi X, Dalal NS: Hydroxyl radical generation in the NADH/microsomal reduction of vanadate. Free Rad Res Commun 17: 369–376, 1992
Shi X, Dalal NS: Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Commun 163: 627–634, 1989
Snyder RD: Role of active oxygen species in metal-induced DNA strand breakage in human diploid fibroblasts. Mutat Res 193: 237–246, 1988
Shackelford RE, Kaufmann WK, Paules RS: Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 107: 5–24, 1999
Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266: 1821–1828, 1994
Mercer WE: Checking on the cell cycle. J Cell Biochem 30/31(suppl): 50–54, 1998
Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511–1517, 1996
Bakke O, Jakobsen K, Eik-Nes KB: Concentration-dependent effects of potassium dichromate on the cell cycle. Cytometry 5: 482–486, 1984
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139: 271–279, 1991
Sgonic R, Wick G: Methods for the detection of apoptosis. Int Arch Allergy Immunol 105: 327–332, 1994
Rosen GM, Finkelstein E: Use of spin traps in biological systems. Adv Free Radical Biol Med 1: 345–375, 1985
Leonard SS, Gannett PM, Rojanasakul Y, Schwegler-Berry D, Castranova V, Vallyathan V, Shi X: Cobalt-mediated generation of reactive oxygen species and its possible mechanism. J Inorg Biochem 70: 239–244, 1998
Ye J, Zhang X, Young HA, Mao Y, Shi X: Chromium (VI)-induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16: 2401–2405, 1995
Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, Shi X: Participation of MAP kinase p38 and IκB kinase in chromium (VI)-induced NF-κB and AP-1 activation. J Environ Pathol Toxicol Oncol 19: 231–238, 2000
Wang S, Leonard SS, Ye J, Ding M, Shi X: The role of hydroxyl radical as a messenger in Cr (VI)-induced p53 activation. Am J Physiol 279: C868–C875, 2000
Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, Appella E: A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270: 29386–29391, 1995
Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN: Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibrosis: p53 and Rb control G1 arrest but not cell replication. Biochem J 332: 43–50, 1998
Morgan DO: Principles of CDK regulation. Nature 374: 131–134, 1995
Draetta G: Cell cycle control in eukaryotes: Molecular mechanisms of Cdc2 activation. Trends Biochem Sci 15: 378–383, 1990
Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441–470, 1993
Pines J, Hunter T: Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58: 833–846, 1989
Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J Biol Chem 274: 34974–34980, 1999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Z., Leonard, S.S., Wang, S. et al. CR (VI) induces cell growth arrest through hydrogen peroxide‐mediated reactions. Mol Cell Biochem 222, 77–83 (2001). https://doi.org/10.1023/A:1017963307358
Issue Date:
DOI: https://doi.org/10.1023/A:1017963307358